Niclosamide intramuscular depot (Daewoong Pharmaceutical/ Institut Pasteur Korea)

N/A

Report date: 2024/12/02 09:41:13

Base Information

Drug NameNiclosamide intramuscular depot (Daewoong Pharmaceutical/ Institut Pasteur Korea)
Drug Alias NameNiclosamide IM Depot (Daewoong Pharmaceutical/ Institut Pasteur Korea)DWRX2003DWRX-2003
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionVirus replication inhibitorsWnt signalling pathway inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co LtdInstitut Pasteur Korea
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A